Home » Stocks » KMPH

KemPharm, Inc. (KMPH)

Stock Price: $0.206 USD 0.000 (0.00%)
Updated May 20, 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 14.94M
Revenue (ttm) 12.30M
Net Income (ttm) -13.94M
Shares Out 70.81M
EPS (ttm) -0.26
PE Ratio n/a
Forward PE 2.97
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day May 20
Last Price $0.206
Previous Close $0.206
Change ($) 0.000
Change (%) 0.00%
Day's Open -
Day's Range 0.206 - 0.000
Day's Volume 0
52-Week Range 0.000 - 0.000

More Stats

Market Cap 14.94M
Enterprise Value 78.18M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 70.81M
Float n/a
EPS (basic) -0.33
EPS (diluted) -0.26
FCF / Share -0.06
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 635,833
Short Ratio 0.41
Short % of Float n/a
Beta 2.69
PE Ratio n/a
Forward PE 2.97
P/FCF Ratio n/a
PS Ratio 1.22
PB Ratio n/a
Revenue 12.30M
Operating Income -6.81M
Net Income -13.94M
Free Cash Flow -3.99M
Net Cash -63.24M
Net Cash / Share -0.87
Gross Margin 80.45%
Operating Margin -55.33%
Profit Margin -113.40%
FCF Margin -32.44%
ROA -31.00%
ROE n/a
ROIC -40.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$1.50*
Low
1.50
Current: $0.206
High
1.50
Target: 1.50
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013
Revenue12.84------
Gross Profit12.84------
Operating Income-20.34-55.90-33.37-37.48-22.81-16.44-4.72
Net Income-24.52-56.47-43.39-16.52-54.66-24.46-5.23
Shares Outstanding29.6517.9314.6514.607.372.382.38
Earnings Per Share-0.83-3.15-2.96-1.13-7.42-10.27-2.20
Operating Cash Flow-23.74-54.20-33.10-29.77-20.27-14.67-4.33
Capital Expenditures-0.03-0.02-0.18-0.64-0.14-0.05-0.03
Free Cash Flow-23.76-54.22-33.28-30.42-20.40-14.72-4.36
Cash & Equivalents3.5622.3843.3368.8751.3210.26-
Total Debt79.5382.0593.4891.9821.9718.95-
Net Cash / Debt-75.97-59.67-50.15-23.1229.35-8.70-
Assets10.5126.7552.4684.8954.5913.71-
Liabilities84.9693.3111010464.7138.02-
Book Value-74.46-66.57-57.52-18.70-10.12-48.51-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name KemPharm, Inc.
Country United States
Employees 22
CEO Travis Mickle

Stock Information

Ticker Symbol KMPH
Stock Exchange US OTC
Sector Healthcare
Industry Biotechnology
Unique Identifier OTCMKTS: KMPH
IPO Date April 16, 2015

Description

KemPharm, a specialty pharmaceutical company, discovers and develops various proprietary prodrugs in the United States. Its product candidate includes KP415 and KP484 for the treatment of attention deficit hyperactivity disorder; and KP879 for the treatment of stimulant use disorder. The company also provides APADAZ, an immediate-release combination product candidate of benzhydrocodone and acetaminophen to treat the short-term management of acute pain. It has a collaboration agreement with KVK-Tech, Inc. to manufacture and commercialize APADAZ. The company was founded in 2006 and is headquartered in Celebration, Florida.